Long-term Effect of Hypnosis in Spinal Cord Injury Patients

December 10, 2019 updated by: Lone Knudsen, MSc Psych, PhD

Coping-oriented hypnotic suggestions aimed at reducing pain catastrophizing was shown to reduce pain in people with chronic tension-type headache and experimental pain in healthy volunteers during hypnosis (Kjøgx et al., 2016). However, the duration of the effect on pain post-hypnosis is unknown.

The aim is to investigate the durational effect of a single session of coping-oriented hypnotic suggestions on chronic pain in patients with spinal cord injury. If effective for a longer period post-hypnosis, this form of hypnosis may provide an alternative to medicine or may be used in conjunction with lower medicine dosages.

Methods: 75 patients with spinal cord injury and pain is randomized into one of three conditions; coping-oriented hypnosis plus current treatment, neutral hypnosis plus current treatment or current treatment only. Pain intensity, coping strategies, pain catastrophizing, anxiety and depression is assessed before intervention and over a period of 14 days post-intervention.

Study Overview

Status

Terminated

Study Type

Interventional

Enrollment (Actual)

7

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Viborg, Denmark, 8800
        • Spinal Cord Injury Centre of Western Denmark

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Spinal cord injury (tetraplegia or paraplegia) with some preservation of hand functioning
  • Baseline pain level of ≥ 3 on a Numeric Rating Scale (NRS; 0-10 where 10 is extremely severe pain)
  • Pain duration of at least 8 weeks.

Exclusion Criteria:

  • Severe mental or psychiatric illness
  • Substance abuse (drugs, alcohol or medicine)
  • Lack of ability to cooperate during the experiment
  • Severe high cervical lesions
  • Severe autonomic dysautonomia

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Coping-oriented hypnosis
Hypnosis using coping-oriented suggestions based on reversal of statements from the pain catastrophizing scale plus current treatment.
PLACEBO_COMPARATOR: Neutral hypnosis
Hypnosis using neutral suggestions plus current treatment
NO_INTERVENTION: current treatment only

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain intensity
Time Frame: For 14 days post-intervention
NRS (0-10)
For 14 days post-intervention
Coping
Time Frame: For 14 days post-intervention
Coping strategies questionnaire
For 14 days post-intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain catastrophizing
Time Frame: For 14 days post-intervention
Pain catastrophizing scale
For 14 days post-intervention
Pain impact on mood, sleep and daily activities
Time Frame: For 14 days post-intervention
NRS (0-10)
For 14 days post-intervention
Anxiety
Time Frame: For 14 days post-intervention
Hospital Anxiety and Depression Scale
For 14 days post-intervention
Depression
Time Frame: For 14 days post-intervention
Hospital Anxiety and Depression Scale
For 14 days post-intervention
Global impression of change
Time Frame: For 14 days post-intervention
Global impression of change scale
For 14 days post-intervention

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Side effects
Time Frame: For 14 days post-intervention
patient report
For 14 days post-intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Helge Kasch, MD, PhD, Spinal Cord Injury Centre of Western Denmark

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

May 17, 2017

Primary Completion (ACTUAL)

November 1, 2019

Study Completion (ACTUAL)

November 1, 2019

Study Registration Dates

First Submitted

February 21, 2017

First Submitted That Met QC Criteria

February 21, 2017

First Posted (ACTUAL)

February 24, 2017

Study Record Updates

Last Update Posted (ACTUAL)

December 12, 2019

Last Update Submitted That Met QC Criteria

December 10, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Spinal Cord Injuries

Clinical Trials on Coping-oriented hypnosis

Subscribe